SA health regulator registers J&J’s COVID-19 vaccine
SOUTH Africa's health regulator has registered Johnson & Johnson’s COVID-19 vaccine, paving the way for deliveries to start in the second quarter. The registration of J&J's vaccine is a boost for the country worst affected by the pandemic on the continent in terms of recorded infections and deaths. South Africa is counting on J&J to supply 31 million doses of its vaccine. J&J said in a statement that the South African Health Products Regulatory Authority (SAHPRA) had "granted registration with conditions" for its single-dose vaccine. SAHPRA's spokesman confirmed that J&J's vaccine had been registered when called by Reuters. He said…